These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 11193195)
1. Function of inflammatory cells and neoral cyclosporin-A in heart transplant-associated coronary vasculopathy. Buján J; Jurado F; Gimeno MJ; Rodriguez M; Bellón JM Histol Histopathol; 2001 Jan; 16(1):197-203. PubMed ID: 11193195 [TBL] [Abstract][Full Text] [Related]
2. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat. Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model. Richter MH; Richter H; Barten M; Schramm D; Weinert M; Gummert J; Mohr FW; Olbrich HG Transplant Proc; 2002 Aug; 34(5):1479-80. PubMed ID: 12176448 [No Abstract] [Full Text] [Related]
4. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model. Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221 [TBL] [Abstract][Full Text] [Related]
5. The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine. Arai S; Teramoto S; Senoo Y J Heart Lung Transplant; 1992; 11(4 Pt 1):757-62. PubMed ID: 1379829 [TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts. Chen Y; Liu Y; Yuan Z; Tian L; Dallman MJ; Thompson PW; Tam PK; Lamb JR Transplantation; 2007 Jun; 83(12):1602-10. PubMed ID: 17589344 [TBL] [Abstract][Full Text] [Related]
7. Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor. Paul LC; Davidoff A; Benediktsson H Transplantation; 1994 Jun; 57(12):1767-72. PubMed ID: 7517077 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response. Maggard MA; Johnson C; Wang T; Terasaki P; Kupiec-Weglinski JW; Busuttil RW; Imagawa DK Transplant Proc; 1999; 31(1-2):728-9. PubMed ID: 10083311 [No Abstract] [Full Text] [Related]
10. Inhibition of graft coronary arteriosclerosis after heart transplantation. Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833 [TBL] [Abstract][Full Text] [Related]
11. Effects of pravastatin on chronic rejection of rat cardiac allografts. Maggard MA; Ke B; Wang T; Kaldas F; Seu P; Busuttil RW; Imagawa DK Transplantation; 1998 Jan; 65(2):149-55. PubMed ID: 9458006 [TBL] [Abstract][Full Text] [Related]
12. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy. Richter MH; Richter HR; Olbrich HG; Mohr FW Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338 [TBL] [Abstract][Full Text] [Related]
13. Role of macrophages in myocardial apoptosis following cardiac transplant. Influence of immunosuppressive treatment. Jurado F; Bellón JM; Golitsin A; Gimeno MJ; Pascual G; Buján J Histol Histopathol; 1999 Oct; 14(4):1033-43. PubMed ID: 10506919 [TBL] [Abstract][Full Text] [Related]
14. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease. Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085 [TBL] [Abstract][Full Text] [Related]
15. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection. Schmid C; Heemann U; Azuma H; Tilney NL Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053 [No Abstract] [Full Text] [Related]
16. Reduction of ICAM-1 and LFA-1-positive leukocytes in the perivascular space of arteries under mycophenolate mofetil therapy reduces rat heart transplant vasculopathy. Richter M; Zahn S; Richter H; Mohr FW; Olbrich HG J Heart Lung Transplant; 2004 Dec; 23(12):1405-13. PubMed ID: 15607671 [TBL] [Abstract][Full Text] [Related]
17. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy. Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761 [TBL] [Abstract][Full Text] [Related]
18. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation. Murphy GJ; Bicknell GR; Nicholson ML Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727 [TBL] [Abstract][Full Text] [Related]
19. Role of ICAM-1 in chronic rejection in the rat heart transplantation model. Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899 [No Abstract] [Full Text] [Related]
20. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine. Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]